Steadfast Invests ₹100 Crore In Integrated Nutraceutical Manufacturing
Steadfast Ltd. invested over ₹100 crore in an integrated nutraceutical manufacturing plant, formulation research and development facility, and quality-control laboratory in Noida, strengthening its domestic manufacturing capabilities.
The facility has an annual production capacity of 900 million tablets, 130 million capsules, 900 million effervescent tablets and 6,500 tonnes of powder. Equipped with more than 140 analytical instruments, its quality-control laboratory will support product testing and quality assessment across manufacturing stages.
Led by CEO Aman Puri, the company plans to expand into specialised nutrition categories, including medical, infant, elderly and women’s nutrition, while developing its contract manufacturing and export business.
#Nutraceuticals #Manufacturing #IndianBusiness #Startup77
